bioMérieux builds Chinese diagnostics presence through acquisition
This article was originally published in Scrip
Executive Summary
bioMérieux has acquired the Chinese rapid diagnostics company Meikang Biotech, in a move aimed at building its presence and capabilities in the fast-growing Chinese market.